PropertyValue
?:abstract
  • Patients with acute Coronavirus-19 (COVID-19) respiratory infections are associated with concomitant thromboembolic complications and a hypercoagulable state. Although these mechanisms are not completely understood, unique alterations in serum markers for hemostasis and thrombosis have been detected. A high index of suspicion is required by vascular surgeons in patients presenting with this novel virus. We present the case of a 51 year old male with acute COVID-19 pneumonia who developed Phlegmasia Cerulea Dolens despite chronic warfarin therapy and a supratherapeutic International Normalized Ratio (INR).
is ?:annotates of
?:creator
?:doi
?:doi
  • 10.1016/j.jvscit.2020.10.002
?:journal
  • J_Vasc_Surg_Cases_Innov_Tech
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/709cbef899046b0731ddd0a16e71dbabb9643b47.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7571495.xml.json
?:pmcid
?:pmid
?:pmid
  • 33102992.0
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:sha_id
?:source
  • Elsevier; Medline; PMC
?:title
  • Phlegmasia Cerulea Dolens Associated with Acute COVID-19 Pneumonia Despite Supratherapeutic Warfarin Anticoagulation
?:type
?:year
  • 2020-10-19

Metadata

Anon_0  
expand all